Expression of CD40 correlates negatively with overall and progression-free 
survival of low- and high-grade gliomas

Werner, Jan-Michael; Kuhl, Saskia; Ulrich, Katharina; Krischek, Boris; Stavrinou, Pantelis; Goldbrunner, Roland; Timer, Marco

doi:10.1016/j.wneu.2019.05.112

Lokale TagsFreigabegeschichteDetailsÜbersicht

Expression of CD40 correlates negatively with overall and progression-free survival of low- and high-grade gliomas

Werner, J.-M., Kuhl, S., Ulrich, K., Krischek, B., Stavrinou, P., Goldbrunner, R., et al. (2019). Expression of CD40 correlates negatively with overall and progression-free survival of low- and high-grade gliomas. World Neurosurgery, 130, E17-E25. doi:10.1016/j.wneu.2019.05.112.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/21.11116/0000-0004-5018-7 Versions-Permalink: https://hdl.handle.net/21.11116/0000-0004-DBC6-6

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Werner, Jan-Michael, Autor
Kuhl, Saskia, Autor
Ulrich, Katharina, Autor
Krischek, Boris, Autor
Stavrinou, Pantelis, Autor
Goldbrunner, Roland, Autor
Timer, Marco¹, Autor

Affiliations:
1In-vivo-NMR, Research Groups, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149666